7d5ebe51-figure-01 (7d5ebe51 Figure 01)
Chemical structure of Gabapentin showing a cyclohexane ring with amino and acetic acid substituents.*
Gabapentin
Product Images NDC 52959-757
6 FDA label images from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 52959-757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
7d5ebe51-figure-02 (7d5ebe51 Figure 02)
A line graph showing mean pain scores over 8 weeks comparing placebo and Gabapentin 3600 mg/day. The x-axis is labeled Weeks with Baseline, and the y-axis shows Mean Pain Score from 0 to 10. Gabapentin shows a decreasing pain score trend during both the 4-week dose titration and 4-week fixed dose periods, while placebo remains relatively constant.*
7d5ebe51-figure-03 (7d5ebe51 Figure 03)
A line graph depicting the mean pain score over seven weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The graph shows two periods: a 3-week dose titration and a 4-week fixed dose period, with pain scores decreasing more for Gabapentin groups than placebo.*
7d5ebe51-figure-04 (7d5ebe51 Figure 04)
A bar chart comparing the percentage of responders at endpoint between placebo (PBO) and Gabapentin (GBP) at doses of 3600 mg, 1800 mg, and 2400 mg across two separate studies. The chart displays significantly higher response rates for Gabapentin groups in both studies, with statistical significance indicated.*
7d5ebe51-figure-05 (7d5ebe51 Figure 05)
A scatter plot illustrating the percentage difference by daily dose (mg) for Gabapentin across three studies labeled as Study a, Study b, and Study c. The x-axis represents the daily dose in milligrams, ranging from about 600 to 1800 mg, and the y-axis shows the percentage difference, ranging from 2% to 22%. Data points are marked with different colored squares for each study.*
7d5ebe51-figure-06 (7d5ebe51 Figure 06)
Gabapentin 100mg capsule label from H.J. Harkins Company, Inc. The label includes lot number GBP105QE, manufacturer Camber PHM in Piscataway, NJ, with expiration 11/12. The capsule is identified as white and oval. The label also shows comparison to Neurontin with manufacturer NDC 31722-221-05, and cautions to use as directed by a doctor. Four attached smaller labels repeat key details and pill identification.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
